{"id":4758,"date":"2023-06-01T07:11:11","date_gmt":"2023-06-01T07:11:11","guid":{"rendered":"https:\/\/www.nflbiosciences.com\/?page_id=4758"},"modified":"2026-02-10T16:20:36","modified_gmt":"2026-02-10T16:20:36","slug":"management-team","status":"publish","type":"page","link":"https:\/\/www.nflbiosciences.com\/en\/management-team\/","title":{"rendered":"Management & Operations"},"content":{"rendered":"

<\/div><\/div>
<\/div>

Management Team<\/span><\/span><\/h1>


\nManagement et Operations<\/div><\/header>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\"bt_bb_section_bottom_section_coverage_image\"<\/div><\/section>
<\/div><\/div>
\r\n\t\t\t
\"Bruno<\/span><\/div>\r\n\t\t<\/div>

Co-Founder, Chairman & CEO<\/span>Bruno Lafont, M.Sc., Executive MBA<\/span><\/span><\/h3><\/header><\/div>
Bruno Lafont co-founded NFL Biosciences in 2009, and is in charge of the structuring and technical development of NFL Biosciences and its various projects.<\/p>\n

Previously, Bruno spent 12 years on the management team of PCM, an international French industrial group, as Innovation Director from 1999 to 2004, then as President and in charge of setting up the group's US subsidiary in Houston (Texas) from 2004 to 2009.<\/p>\n

Bruno holds an engineering degree in biochemistry from the Institut National des Sciences Appliqu\u00e9es (INSA) in Toulouse, a Master's degree in management from EMLyon, and an Executive MBA from the Ecole Polytechnique F\u00e9d\u00e9rale de Lausanne and HEC Lausanne.<\/div>

<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\r\n\t\t\t
\"Ignacio<\/span><\/div>\r\n\t\t<\/div>

Managing Director<\/span>Ignacio Faus, Ph.D., MBA<\/span><\/span><\/h3><\/header><\/div>
Dr. Ignacio Faus joined NFL Biosciences in 2019 as an investor, then the management team in early 2021.<\/p>\n

Dr. Ignacio Faus has 27 years' experience in large and medium-sized pharmaceutical companies, as well as in private and listed biotech companies: Bristol Myers Squibb, Grupo Uriach, Ferrer and co-founder in 2006 and Managing Director of Palau Pharma (sold in 2013). In recent years, Ignacio Faus has also been a director of several private and listed biotech companies and private equity funds in Europe and the United States.<\/p>\n

Ignacio holds a PhD in Biochemistry (Indiana University, USA) and an MBA in Entrepreneurship and Finance from the Kellogg School of Management (Northwestern University, USA).<\/div>

<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\r\n\t\t\t
\"Yannick<\/span><\/div>\r\n\t\t<\/div>

Board Member - Chief Medical Officer<\/span>Yannick Pl\u00e9tan, M.D., Dr.<\/span><\/span><\/h3><\/header><\/div>
Yannick Pl\u00e9tan holds degrees in pneumology, immunology, clinical pharmacology and pharmacokinetics - post-doctorate at INSERM and visiting professor at the University of California Davis. After practicing hospital medicine for several years, he joined the pharmaceutical industry, where he held senior management positions for 20 years in R&D and medical affairs at Sanofi, Institut de Recherche Pierre Fabre, Pfizer and Roche-Genentech. He played a central role in the creation and worldwide development of the nicotine patch, and in the later development and launch of Chantix\u00ae.<\/div>
<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div>
\r\n\t\t\t
\"Lara<\/span><\/div>\r\n\t\t<\/div>

Head of Development and Manufacturing<\/span>Lara Babich, Ph.D.<\/span><\/span><\/h3><\/header><\/div>
Lara joined NFL Biosciences in 2024.<\/p>\n

She worked as formulation and process scientist for vaccine development at Janssen Infectious Diseases and Vaccines in the Netherlands. In 2018 she joined the Australian biotech Noxopharm, where she was responsible for the CMC development, manufacturing and clinical supply for several international clinical trials.<\/p>\n

Lara is graduating in industrial biotechnology at the University of Padova in Italy, and she obtained a doctorate in biochemistry from the University of Amsterdam in 2013. <\/div>

<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\r\n\t\t\t
\"Guillaume<\/span><\/div>\r\n\t\t<\/div>

Chief Financial Officer<\/span>Guillaume Audema<\/span><\/span><\/h3><\/header><\/div>
Guillaume Audema joined NFL Biosciences' Finance Department at the beginning of 2022.<\/p>\n

Guillaume spent 7 years with the international firms KPMG and then PWC, working on audit and advisory assignments in the organizational and financial fields for companies of all sizes, notably listed on the French and American financial markets. Before joining the team, he spent 3 years on a financial structuring assignment for an SME.<\/p>\n

Guillaume holds a Master's degree in Accounting and Controlling from the University of Montpellier and a Dipl\u00f4me Sup\u00e9rieur de Comptabilit\u00e9 et de Gestion.<\/div>

<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\r\n\t\t\t
\"Marie-Laure<\/span><\/div>\r\n\t\t<\/div>

Senior Clinical Project Leader<\/span>Marie-Laure Fraisse, M.Sc.<\/span><\/span><\/h3><\/header><\/div>
Marie Laure Fraisse joined NFL Biosciences in 2021.<\/p>\n

After working as a nurse in a number of hospitals for 4 years, Marie-Laure moved into the monitoring and management of clinical studies. Marie-Laure was a Clinical Research Associate (CRA) at Servier Laboratories and then at the H\u00f4pital R\u00e9gional d'Annecy, before joining Merck Sereno as Clinical Project Manager and Director. She then worked for Th\u00e9a and Medincell laboratories.<\/p>\n

Marie-Laure Fraisse holds a nursing diploma and a master's degree in drug development from EudiPharm in Lyon.<\/div>

<\/div>
<\/a><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4758","page","type-page","status-publish","hentry"],"yoast_head":"\nManagement & Operations - NFL Biosciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.nflbiosciences.com\/en\/management-team\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Management & Operations - NFL Biosciences\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.nflbiosciences.com\/en\/management-team\/\" \/>\n<meta property=\"og:site_name\" content=\"NFL Biosciences\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-10T16:20:36+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/management-team\\\/\",\"url\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/management-team\\\/\",\"name\":\"Management & Operations - NFL Biosciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/#website\"},\"datePublished\":\"2023-06-01T07:11:11+00:00\",\"dateModified\":\"2026-02-10T16:20:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/management-team\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/management-team\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/management-team\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Management & Operations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/\",\"name\":\"NFL Biosciences\",\"description\":\"Rendre possible l'arr\u00eat du tabac\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.nflbiosciences.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Management & Operations - NFL Biosciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.nflbiosciences.com\/en\/management-team\/","og_locale":"en_US","og_type":"article","og_title":"Management & Operations - NFL Biosciences","og_url":"https:\/\/www.nflbiosciences.com\/en\/management-team\/","og_site_name":"NFL Biosciences","article_modified_time":"2026-02-10T16:20:36+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.nflbiosciences.com\/en\/management-team\/","url":"https:\/\/www.nflbiosciences.com\/en\/management-team\/","name":"Management & Operations - NFL Biosciences","isPartOf":{"@id":"https:\/\/www.nflbiosciences.com\/en\/#website"},"datePublished":"2023-06-01T07:11:11+00:00","dateModified":"2026-02-10T16:20:36+00:00","breadcrumb":{"@id":"https:\/\/www.nflbiosciences.com\/en\/management-team\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.nflbiosciences.com\/en\/management-team\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.nflbiosciences.com\/en\/management-team\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.nflbiosciences.com\/en\/"},{"@type":"ListItem","position":2,"name":"Management & Operations"}]},{"@type":"WebSite","@id":"https:\/\/www.nflbiosciences.com\/en\/#website","url":"https:\/\/www.nflbiosciences.com\/en\/","name":"NFL Biosciences","description":"Rendre possible l'arr\u00eat du tabac","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.nflbiosciences.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/pages\/4758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/comments?post=4758"}],"version-history":[{"count":22,"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/pages\/4758\/revisions"}],"predecessor-version":[{"id":6544,"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/pages\/4758\/revisions\/6544"}],"wp:attachment":[{"href":"https:\/\/www.nflbiosciences.com\/en\/wp-json\/wp\/v2\/media?parent=4758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}